Share “Bristol-Myers enters three-year...”

Bristol-Myers enters three-year collaboration deal

Published on NewsOK Modified: February 12, 2013 at 7:19 am •  Published: February 12, 2013

NEW YORK (AP) — Bristol-Myers Squibb Co. will receive more than $480 million from a collaboration agreement with British consumer goods company Reckitt Benckiser Group PLC over the sale of several over-the-counter drugs mostly in Mexico and Brazil.

The New York drug developer said Tuesday Reckitt Benckiser will pay $438 million upfront for exclusive rights to sell products like the antacid Picot, the pain reliever Tempra and the cold-and-cough medicine Graneodin over three years. Reckitt Benckiser will buy the products from Bristol and pay royalties during the collaboration.

The British company also will pay an option fee of $44 million for the right to buy the products outright at the end of the three-year agreement. That includes acquiring sales and distribution rights, trademarks, inventories and other assets. The purchase price then will be based on average sales during a two-year period before the deal closes.

Bristol-Myers Squibb shares finished at $36.93 on Monday.


  1. 1
    Former OSU student convicted of manslaughter in 2009 fatal car crash released on bail; attorney...
  2. 2
    Police find dead body in porta-potty outside Cincinnati Bengals' Paul Brown Stadium
  3. 3
    Several Deer Creek schools on lockdown due to report of suspicious person
  4. 4
    Tulsa mother gets three life sentences, father 25 years in 'horrific' child abuse case
  5. 5
    Man who calls police to say he's 'too high,' found in pile of Doritos
+ show more


× Trending business Article